Damali N. Martin, Ph.D., M.P.H.
Program Director, Genomic Epidemiology Branch

Address:
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E108, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)

Interest Areas

  • Cancer disparities in underserved populations
  • Cancer epidemiologic research in understudied populations
  • Global health and cancer epidemiology
  • Cancer registry development in the Caribbean

Degrees

  • Ph.D. - Cell biology and Molecular Genetics
    University of Maryland, College Park
  • M.P.H. - Epidemiology and Biostatistics
    The Johns Hopkins Bloomberg School of Public Health
  • B.S. - Cell Biology and Molecular Genetics
    University of Maryland, College Park

Biography

Dr. Damali Martin is a Program Director in the Genomic Epidemiology Branch (GEB)—formerly the Host Susceptibility Factors Branch (HSFB)—of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). Dr. Martin's responsibilities include managing a portfolio of grants related to the genetic etiology of cancers and subsequent health outcomes in underserved populations globally. She focuses on improving understanding of cancer disparities in the U.S. and internationally, particularly populations of African descent. She works collaboratively to implement EGRP's activities related to the Sequencing Strategies for Population and Cancer Epidemiology Studies (SeqSPACE), Cancer Epidemiologic Research in Understudied Populations, and Infectious Agents and Cancer Epidemiology Research Webinar Series.

Dr. Martin is involved in numerous global health and international research activities and she is EGRP's Global Health Coordinator. Dr. Martin is active in the National Institute of Health (NIH) Global Environmental and Occupational Health (GEOHealthExternal Web Site Policy) program, serving as the U.S. Government collaborator to the Suriname GEOHealth Hub. She also serves as the scientific officer for the trans-NIH Human Heredity and Health in Africa Initiative (H3AfricaExternal Web Site Policy) Dr. Martin is a member of the NIH Common Fund's Global HealthExternal Web Site Policy Implementation team.

Dr. Martin is the EGRP liaison for several international research consortia in developing countries, including the Men of African Descent and Carcinoma of the Prostate Consortium (MADCaP), the Prostate Cancer Transatlantic Consortium (CaPTC), the African-American Breast Cancer Consortium (AABC), and the African-Caribbean Cancer ConsortiumExternal Web Site Policy (AC3). She serves as NCI's program coordinator for the International Agency for Research on Cancer (IARC) Caribbean Regional Cancer Registry Hub, under their Global Initiative for Cancer RegistriesExternal Web Site Policy in Developing Countries.

Before joining EGRP in 2008, Dr. Martin was a Cancer Prevention Fellow at NCI and worked in the Laboratory of Human Carcinogenesis in NCI's Center for Cancer Research. Her research examined molecular epidemiology and the biological determinants of cancer disparities in African Americans, with the goal of understanding mechanisms of the disease to identify targets for new prevention and treatment efforts. Dr. Martin's research also focused on elucidating the differences in biology found with a higher prevalence in breast tumors from African-American women and whether they contribute to the lower survival and higher mortality observed among this group of women.

During her M.P.H. studies, Dr. Martin worked on the Jamaican Cervical Dysplasia project and examined human papillomavirus (HPV) viral load and its association with stage and grade of cervical neoplasia.

Publications

Martin DN, Lam TK, Brignole K, Ashing KT, Blot WJ, Burhansstipanov L, Chen JT, Dignan M, Gomez SL, Martinez ME, Matthews A, Palmer JR, Perez-Stable EJ, Schootman M, Vilchis H, Vu A, Srinivasan S. Recommendations for Cancer Epidemiologic Research in Understudied Populations and Implications for Future NeedsExternal Web Site Policy. Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):573-80.

Prueitt RL, Wallace TA, Glynn SA, Yi M, Tang W, Luo J, Dorsey TH, Stagliano KE, Gillespie JW, Hudson RS, Terunuma A, Shoe JL, Haines DC, Yfantis HG, Han M, Martin DN, Jordan SV, Borin JF, Naslund MJ, Alexander RB, Stephens RM, Loffredo CA, Lee DH, Putluri N, Sreekumar A, Hurwitz AA, Ambs S. An Immune-Inflammation Gene Expression Signature in Prostate Tumors of SmokersExternal Web Site Policy. Cancer Res. 2016 Mar 1;76(5):1055-65.

Banydeen R, Rose AM, Martin D, Aiken W, Alexis C, Andall-Brereton G, Ashing K, Avery JG, Avery P, Deloumeaux J, Ekomaye N, Gabriel O, Hassell T, Hughes L, Hutton M, Jyoti SK, Layne P, Luce D, Patrick A, Prussia P, Smith-Ravin J, Veronique-Baudin J, Blackman E, Roach V, Ragin C. Advancing Cancer Control Through Research and Cancer Registry Collaborations in the CaribbeanExternal Web Site Policy. Cancer Control. 2015 Oct;22(4):520-30.

Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, Parkin DM, Rebbeck TR, Ross H, Santini LA, Torode J, Trimble EL, Wild CP, Young AM, Kerr DJ. Building capacity for sustainable research programmes for cancer in AfricaExternal Web Site Policy. Nat Rev Clin Oncol. 2014 May;11(5):251-9.

Return to Top